Table 1.
Cohort A (n=12) | Cohort B (n=7) | Cohort C (n=11) | Cohort D (n=6) | Cohort E (n=3) | Total (n=39) | |
---|---|---|---|---|---|---|
Age | ||||||
Median | 51.0 | 59.0 | 63.0 | 64.5 | 48.0 | 56.0 |
Range | (25.0–74.0) | (46.0–78.0) | (38.0–76.0) | (28.0–80.0) | (35.0–56.0) | (25.0–80.0) |
Gender | ||||||
Female | 9 | 3 | 8 | 3 | 2 | 25 |
Male | 3 | 4 | 3 | 3 | 1 | 14 |
Performance score | ||||||
0 | 6 | 4 | 4 | 3 | 1 | 18 |
1 | 6 | 3 | 7 | 3 | 2 | 21 |
Prior chemotherapy | ||||||
Yes | 12 | 7 | 10 | 6 | 3 | 38 |
Prior surgery | ||||||
Yes | 12 | 7 | 11 | 6 | 3 | 39 |
Prior radiation | ||||||
Yes | 5 | 4 | 5 | 2 | 1 | 17 |
No | 7 | 3 | 6 | 4 | 2 | 22 |
Primary site | ||||||
Ovarian | 3 | 2 | 0 | 1 | 1 | 7 |
Lung | 3 | 1 | 1 | 0 | 0 | 5 |
Other | 6 | 4 | 10 | 5 | 2 | 27 |